Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
3.800
+0.200 (5.56%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Femasys Employees
As of December 31, 2025, Femasys had 54 total employees, including 51 full-time and 3 part-time employees. The number of employees decreased by 17 or -23.94% compared to the previous year.
Employees
54
Change (1Y)
-17
Growth (1Y)
-23.94%
Revenue / Employee
$44,017
Profits / Employee
-$229,674
Market Cap
11.47M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 201 |
| Bionano Genomics | 97 |
| Nephros | 36 |
| NEXGEL | 19 |
| Zentek | 18 |
| Milestone Scientific | 15 |
FEMY News
- 3 days ago - Femasys regains compliance with Nasdaq - TheFly
- 3 days ago - Femasys Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 22 days ago - Femasys Inc trading halted, news pending - TheFly
- 6 weeks ago - Femasys announces CE Mark approval for FemHSG Catheter - TheFly
- 6 weeks ago - Femasys Expands Fertility Care Portfolio in Europe with CE Mark Approval for FemHSG™ Catheter - GlobeNewsWire
- 6 weeks ago - Femasys Slides: Corporate presentation - Filings
- 7 weeks ago - Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Femasys Quarterly report: Q1 2026 - Filings